Amedisys to Be Acquired by UnitedHealth Group’s Optum in $3.3 Billion Deal

Paul, Weiss is advising Amedisys, Inc., a leading provider of home health, hospice and high-acuity care, in its all-cash acquisition by Optum for $101 per share, valuing the company at $3.3 billion. Optum is a diversified health services company and UnitedHealth Group subsidiary. The combination will create a scaled national platform for home and alternate site care. The transaction is subject to approval by regulators and Amedisys shareholders, and other customary closing conditions.

The Paul, Weiss team is led by M&A partners Kyle Seifried and Krishna Veeraraghavan, and includes, among others, corporate partner Christopher Cummings and counsel Benjamin Goodchild, Amanda Gill, Steve Centa and Frances Mi; executive compensation partner Jean McLoughlin and counsel Sasha Belinkie; tax partner Brian Krause; litigation partners Geoffrey Chepiga and Joshua Soven, and counsel Steven Herzog and Jared Nagley; intellectual property partner Jonathan Ashtor and counsel Marisa Geiger; real estate partner Peter Fisch; antitrust counsel Marta Kelly; and environmental counsel William O’Brien.